In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold.
This study was designed to investigate the in vivo biodegration and biocompatibility of a poly(propylene fumarate) (PPF)-based orthopedic biomaterial. The effects of varying the PPF to N-vinyl pyrrolidinone ratio and PPF to beta-tricalcium phosphate content were studied. The composite mechanical properties and local tissue interactions were analyzed over 12 weeks. An initial increase in both compressive modulus and strength was seen for composite formulations that incorporated beta-tricalcium phosphate. The samples incorporating a higher PPF to N-vinyl pyrrolidinone ratio reached a maximal compressive strength of 7.7 MPa and a maximal compressive modulus of 191.4 MPa at 3 weeks. The lower PPF to N-vinyl pyrrolidinone ratio samples gained a maximum compressive strength of 7.5 MPa initially and a compressive modulus of 134.0 MPa at 1 week. At 6 weeks, all samples for formulations incorporating beta-tricalcium phosphate crumbled upon removal and were not mechanically tested. Samples that did not incorporate beta-tricalcium phosphate were very weak and insufficient for bone replacement at the 4-day time point and beyond. Tissue interactions resulted in a mild inflammatory response at the initial time points and mature fibrous encapsulation by 12 weeks.
Peter
S J
SJ
Institute of Biosciences and Bioengineering and Department of Chemical Engineering, Rice University, Houston, Texas 77005-1892, USA.
Miller
S T
ST
Zhu
G
G
Yasko
A W
AW
Mikos
A G
AG
D000818:Animals; D001672:Biocompatible Materials / Q000009:adverse effects / Q000378:metabolism*; D001673:Biodegradation, Environmental; D001861:Bone Regeneration; D002130:Calcium Phosphates / Q000009:adverse effects / Q000378:metabolism*; D003188:Composite Resins / Q000009:adverse effects / Q000378:metabolism*; D005650:Fumarates / Q000009:adverse effects / Q000378:metabolism*; D048091:Guided Tissue Regeneration; D007249:Inflammation / Q000139:chemically induced; D008297:Male; D008422:Materials Testing; D011126:Polypropylenes / Q000009:adverse effects / Q000378:metabolism*; D051381:Rats; D011917:Rats, Inbred Lew
D001672:Biocompatible Materials; D002130:Calcium Phosphates; D003188:Composite Resins; D005650:Fumarates; D011126:Polypropylenes; C485817:beta-tricalcium phosphate; C097850:poly(propylene fumarate); C018392:tricalcium phosphate